Join Dr. Donna Ryan, Professor Emeritus at Pennington Biomedical Research Center at Baton
Rouge in Louisiana, alongside leading experts in the field of obesity and weight management, as they dive into challenges and strategies for the treatment of obesity in this podcast series. Discussion topics will include when to add an anti-obesity medication (AOM) to treat obesity, establishing the efficacy and safety of an AOM, sustaining weight loss, as well as dosing and administration information.
All content for The 411 on Obesity is the property of Novo Nordisk and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join Dr. Donna Ryan, Professor Emeritus at Pennington Biomedical Research Center at Baton
Rouge in Louisiana, alongside leading experts in the field of obesity and weight management, as they dive into challenges and strategies for the treatment of obesity in this podcast series. Discussion topics will include when to add an anti-obesity medication (AOM) to treat obesity, establishing the efficacy and safety of an AOM, sustaining weight loss, as well as dosing and administration information.
The Dos and Don'ts of Obesity Medication Dosing and Administration
The 411 on Obesity
37 minutes 48 seconds
8 months ago
The Dos and Don'ts of Obesity Medication Dosing and Administration
Join experts in obesity: Dr Donna Ryan and Dr Lawrence Herman as they discuss important dosing and administration considerations for a medicine for chronic weight management for adults with overweight with at least one weight related comorbidity and obesity.
The 411 on Obesity
Join Dr. Donna Ryan, Professor Emeritus at Pennington Biomedical Research Center at Baton
Rouge in Louisiana, alongside leading experts in the field of obesity and weight management, as they dive into challenges and strategies for the treatment of obesity in this podcast series. Discussion topics will include when to add an anti-obesity medication (AOM) to treat obesity, establishing the efficacy and safety of an AOM, sustaining weight loss, as well as dosing and administration information.
